153 related articles for article (PubMed ID: 11954675)
1. Use of a false recognition paradigm in an Alzheimer's disease clinical trial: a pilot study.
Budson AE; Michalska KJ; Rentz DM; Joubert CC; Daffner KR; Schacter DL; Sperling RA
Am J Alzheimers Dis Other Demen; 2002; 17(2):93-100. PubMed ID: 11954675
[TBL] [Abstract][Full Text] [Related]
2. Gist memory in Alzheimer's disease: evidence from categorized pictures.
Budson AE; Todman RW; Schacter DL
Neuropsychology; 2006 Jan; 20(1):113-22. PubMed ID: 16460227
[TBL] [Abstract][Full Text] [Related]
3. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
[TBL] [Abstract][Full Text] [Related]
4. False item recognition in patients with Alzheimer's disease.
Abe N; Fujii T; Nishio Y; Iizuka O; Kanno S; Kikuchi H; Takagi M; Hiraoka K; Yamasaki H; Choi H; Hirayama K; Shinohara M; Mori E
Neuropsychologia; 2011 Jun; 49(7):1897-902. PubMed ID: 21419789
[TBL] [Abstract][Full Text] [Related]
5. False recollection of emotional pictures in Alzheimer's disease.
Gallo DA; Foster KT; Wong JT; Bennett DA
Neuropsychologia; 2010 Oct; 48(12):3614-8. PubMed ID: 20727904
[TBL] [Abstract][Full Text] [Related]
6. Brain metabolic effects of Neotrofin in patients with Alzheimer's disease.
Potkin SG; Alva G; Keator D; Carreon D; Fleming K; Fallon JH
Brain Res; 2002 Sep; 951(1):87-95. PubMed ID: 12231461
[TBL] [Abstract][Full Text] [Related]
7. The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.
Doraiswamy PM; Kaiser L; Bieber F; Garman RL
Alzheimer Dis Assoc Disord; 2001; 15(4):174-83. PubMed ID: 11723368
[TBL] [Abstract][Full Text] [Related]
8. The Effectiveness of Item-Specific Encoding and Conservative Responding to Reduce False Memories in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia.
Malone C; Turk KW; Palumbo R; Budson AE
J Int Neuropsychol Soc; 2021 Mar; 27(3):227-238. PubMed ID: 32772946
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical Bayesian cognitive processing models to analyze clinical trial data.
Shankle WR; Hara J; Mangrola T; Hendrix S; Alva G; Lee MD
Alzheimers Dement; 2013 Jul; 9(4):422-8. PubMed ID: 23123230
[TBL] [Abstract][Full Text] [Related]
10. When false recognition is unopposed by true recognition: gist-based memory distortion in Alzheimer's disease.
Budson AE; Daffner KR; Desikan R; Schacter DL
Neuropsychology; 2000 Apr; 14(2):277-87. PubMed ID: 10791867
[TBL] [Abstract][Full Text] [Related]
11. Overdependence on degraded gist memory in Alzheimer's disease.
Gallo DA; Shahid KR; Olson MA; Solomon TM; Schacter DL; Budson AE
Neuropsychology; 2006 Nov; 20(6):625-32. PubMed ID: 17100507
[TBL] [Abstract][Full Text] [Related]
12. Neotrofin clinical trials show promise.
Am J Alzheimers Dis Other Demen; 2001; 16(1):8-9. PubMed ID: 11416953
[No Abstract] [Full Text] [Related]
13. The effects of methylphenidate on learning in children with ADDH: the stimulus equivalence paradigm.
Vyse SA; Rapport MD
J Consult Clin Psychol; 1989 Jun; 57(3):425-435. PubMed ID: 2661612
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of false memory in dementia with Lewy bodies and Alzheimer's disease.
Phillipps C; Kemp J; Jacob C; Veronneau A; Albasser T; Philippi N; Cretin B; Bernard F; Blanc F
Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):332-40. PubMed ID: 27651015
[TBL] [Abstract][Full Text] [Related]
15. Differential responsivity of verbal and visual recognition memory to physostigmine and ACTH.
Rose RP; Moulthrop MA
Biol Psychiatry; 1986 May; 21(5-6):538-42. PubMed ID: 3008865
[No Abstract] [Full Text] [Related]
16. Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer's Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial.
Vila-Castelar C; Ly JJ; Kaplan L; Van Dyk K; Berger JT; Macina LO; Stewart JL; Foldi NS
Arch Clin Neuropsychol; 2019 May; 34(3):277-289. PubMed ID: 29635383
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.
Grove RA; Harrington CM; Mahler A; Beresford I; Maruff P; Lowy MT; Nicholls AP; Boardley RL; Berges AC; Nathan PJ; Horrigan JP
Curr Alzheimer Res; 2014 Jan; 11(1):47-58. PubMed ID: 24359500
[TBL] [Abstract][Full Text] [Related]
18. Treating dementia patients with vascular lesions with donepezil: a preliminary analysis.
Thomas DA; Libon DJ; Ledakis GE
Appl Neuropsychol; 2005; 12(1):12-8. PubMed ID: 15788218
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
[TBL] [Abstract][Full Text] [Related]
20. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Rombouts SA; Barkhof F; Van Meel CS; Scheltens P
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):665-71. PubMed ID: 12438467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
